Bio-Equivalency Studies in Armenia                 
DarmanTest Laboratories, LLC - A CRO specializing in
Bio-Equivalence and Analytical Studies

  A Contract Research Organization (CRO) in full compliance with U.S. Food and
  Drug Administration (FDA), European Medicines Agency (EMA), International    
  Conference on Harmonization Good Clinical Practice (ICH GCP), Good
  Laboratory Practice (GLP) and Good Documentation Practice (GDP).

  Founded and managed by American-Armenian professionals, with a 
  primary focus on bio-equivalence and bio-availability studies, DTL offers its 
  services to generic pharmaceutical companies worldwide.  DTL has a staff of
  young dedicated, motivated and enthusiastic, Doctors, Chemists,
  Pharmacists, Statisticians and administrative staff who are  eager to deliver
  high quality and timely work for our clients. Our staff has not only passed
  advanced mandatory GLP, GCP and GDocP training, but is multilingual
  as well, with fluency  in  English, Armenian, Russian, French, Spanish, Italian,  
  Arabic and Farsi.

  DTL is the first of its kind, state-of-the-art, Bio-Equivalence and Analytical
  Laboratory in Armenia and the CIS region that maintains and conforms to the
  highest level of standards required by the U.S. & European regulatory

DarmanTest Laboratories and Research Center
Դարմանթեստ Լաբորատորիս Հետազոտական Կենտրոն

News & Events

April, 2014
DTL receives a new AB Sciex 4500 MS/MS and two new Shimadzu Nexera X2 UHPLC's

November 20 -22, 2013
Participation in the 6th Annual European Bioanalytical Forum in Barcelona, Spain.

October, 22-24, 2013
Participation in CPhI Worldwide Pharmaceutical
Conference and Trade Show, with approximately 25,000 - 30,000 attendees.

August 22, 2013
Astghik Mikayelyan, our Laboratory Manager planted the DTL flag on top of Mount Ararat.
Congratulations Astghik.  We're proud of you.

 July 22 - August 3, 2013
 DTL underwent a two week pre-study audit and
 inspection by Vantage Bio-Trials of Montreal, 
 Canada in prepartation for a U.S. Food and Drug 
 Administration audit and inspection.

 July 15, 2013
 DTL completes construction of its second floor 
 which will house up to 50+ Study Subjects for its 
 Bio-Equivalence Studies.

Copyright © 2013 Darmantest Laboratories
Template courtesy of Creativement Ltd.
Chromotography Analysis